STOCK TITAN

BlackRock (NHI) reports 8.52M shares, 17.6% stake in National Health

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. amends a Schedule 13G to report beneficial ownership of National Health Investors Inc. common stock. The filing states 8,523,688 shares beneficially owned, representing 17.6% of the class as of 06/30/2026. The filing lists 8,387,095 shares with sole voting power and cites an iShares Core S&P Small‑Cap ETF position exceeding 5%.

Positive

  • None.

Negative

  • None.
Beneficially owned 8,523,688 shares Amount beneficially owned as of 06/30/2026
Percent of class 17.6% Percent of total outstanding common stock as reported
Sole voting power 8,387,095 shares Sole power to vote or direct the vote
Sole dispositive power 8,523,688 shares Sole power to dispose or direct disposition
Snapshot date 06/30/2026 Date tied to reported ownership figures
Schedule 13G/A regulatory
"In accordance with SEC Release No. 34-39538"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned regulatory
"Amount beneficially owned: 8523688"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 8523688"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Reporting Business Units other
"reflects the securities beneficially owned ... by certain business units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does BlackRock report in NHI?

BlackRock reports 8,523,688 shares of National Health Investors Inc., equal to 17.6% of the class as of 06/30/2026. The filing discloses sole voting power for 8,387,095 shares and sole dispositive power for 8,523,688 shares.

Does the Schedule 13G/A show BlackRock controls NHI votes?

The filing shows BlackRock has sole power to vote over 8,387,095 shares and sole dispositive power over 8,523,688 shares. It reports voting and dispositive authority but does not state any control actions or agreements in this excerpt.

What date is the reported ownership tied to in the filing for NHI?

The ownership figures in the amendment are tied to 06/30/2026. The schedule is signed on 07/08/2026, and the reported percentages and share counts reference the 06/30/2026 ownership snapshot.

Is any other entity shown with a >5% stake in NHI?

Yes. The filing identifies iShares Core S&P Small‑Cap ETF as having an interest greater than 5% in National Health Investors Inc. The schedule does not provide that ETF's exact share count in the provided excerpt.

Who signed the Schedule 13G/A for BlackRock regarding NHI?

The amendment is signed by Spencer Fleming, listed as Managing Director, with signature date 07/08/2026. The filing includes Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7 subsidiary details).





63633D104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:07/08/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7